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Abstract
Management of spondylodiscitis is a challenging clinical problem requiring medical and surgical 
treatment strategies. The purpose of this study was to establish a rat model of spondylodiscitis that 
utilizes bioluminescent Staphylococcus aureus, thus permitting in-vivo surveillance of infection 
intensity. Inocula of the bioluminescent S. aureus strain XEN36 were created in concentrations of 
102 CFU/0.1 mL, 104 CFU/0.1 mL, and 106 CFU/0.1 mL. Three groups of rats were injected with 
the bacteria in the most proximal intervertebral tail segment. The third most proximal tail segment 
was injected with saline as a control. Bioluminescence was measured at baseline, 3 days, and 
weekly for a total of 6 weeks. Detected bioluminescence for each group peaked at day three and 
returned to baseline at 21 days. The average intensity was highest for the experimental group 
injected with the most concentrated bacterial solution (106 CFU/0.1 mL). Radiographic analysis 
revealed loss of intervertebral disc space and evidence of osseous bridging. Saline injected spaces 
exhibited no decrease in intervertebral spacing as compared to distal sites. Histologic analysis 
revealed neutrophilic infiltrates, destruction of the annulus fibrosus and nucleus pulposus, 
destruction of vertebral endplates, and osseous bridging. Saline injected discs exhibited preserved 
annulus fibrosus and nucleus pulposus on histology. This study demonstrates that injection of 
bioluminescent S. aureus into the intervertebral disc of a rat tail is a viable animal model for 
spondylodiscitis research. This model allows for real-time, in-vivo quantification of infection 
intensity, which may decrease the number of animals required for infection studies of the 
intervertebral disc.
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The annual incidence of spondylodiscitis is reported to be 2.2 cases per 100,0001. The 
incidence, however is rising, likely due to a growing number of immunosuppressed patients, 
an aging population, and the emerging epidemic of intravenous drug abuse2–4. The impact of 
this condition is made worse by the fact that these patients often have a less robust 
physiologic reserve5. Additionally, the indolent and nonspecific course of discitis often 
delays diagnosis and therefore limits early intervention. As a result, patients hospitalized 
with this condition have estimated in-hospital mortality rates as high as 10% and average 
lengths of stay greater than 30 days6–10. Despite successful treatment of the infection, these 
patients exhibit far lower quality of life than that of the general population, and can develop 
chronic motor and sensory deficits10; 11. The combination of a compromised host and an 
established infection usually requires a protracted treatment course that may include surgical 
intervention.
Treatment of spondylodiscitis with conventional intravenous antibiotics is often unsuccessful 
due to restricted drug penetration. The avascular nature of the intervertebral disc leads to an 
immune privileged environment that permits successful seeding and persistence of bacteria. 
As a result, successful antimicrobial therapy often requires high dosages for prolonged 
periods of time. Despite this limitation, antibiotic treatment remains the cornerstone of 
current spondylodiscitis management12–14. Prolonged infections that fail antibiotic treatment 
often require operative intervention, and thus expose patients to the risks of surgery, 
increasing the healthcare expenses required for successful treatment.
The medical management of spondylodiscitis has not changed significantly in several 
decades, and there is substantial potential for the development of novel treatments in this 
field. Current animal models of spondylodiscitis are technically challenging, requiring 
paravertebral muscle dissection, intensive anesthesia protocols, and intraoperative 
fluoroscopy15–24. As a result, these models require significant expense to establish infection 
and require euthanasia of the host specimen to quantify infection intensity. Recently 
developed animal models of infection have focused on non-invasive methods for the 
longitudinal quantification of infection intensity, with bioluminescent imaging becoming 
increasingly more popular25–27. The purpose of this study was to develop a preclinical 
model of spondylodiscitis that reproducibly creates an infection of the intervertebral disc 
that could be quantified in-vivo utilizing bioluminescent Staphylococcus aureus. This model 
obviates the need to euthanize animals at punctuated time points to study therapeutic effects. 
We hypothesized that inoculation of the S. aureus strain XEN36 into the intervertebral disc 
space of a Sprague-Dawley rat tail would consistently produce a sustained, non-lethal 
bacterial infection that could be quantified and followed over time using the in-vivo imaging 
system (IVIS) technology. Here we report successful development of this rat tail 
spondylodiscitis model that permits real-time monitoring of infection intensity.
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Staphylococcus aureus is the most common cause of clinical spondylodiscitis, and therefore 
we selected a bioluminescent strain of this pathogen for this model. XEN36 S. aureus 
(ATCC 49525 (Perkin Elmer, Waltham, MA)) possesses a Photorhabdus luminescens 
luxABCDE operon on a native plasmid, which produces a bioluminescent signal. Prior to 
surgery, a sample of XEN36 stock solution was streaked onto a Remel blood agar plate 
(Lenexa, KS) and incubated for 18 hours at 37° C. Eighteen hours prior to surgery, 4 
colonies of XEN36 were harvested and suspended in 5 mL of brain-heart Infusion (BHI) 
broth (Becton Dickinson and Co., Franklin Lakes, NJ) and again incubated at 37° C for 18 
hours. Immediately prior to inoculation, the samples were centrifuged at 3,000 g for 15 
minutes, the solution was decanted, and the pellet was resuspended in 10 mL of phosphate 
buffered saline without magnesium or calcium (PBS). The sample was subsequently diluted 
with PBS until an optical density measurement of 0.5 at 600 nanometers (BioMate 3, 
Thermo Fisher Scientific, Waltham, MA) was obtained, which equates to a concentration of 
1.0 × 108 colony forming units per milliliter (CFU/mL). This sample was then serially 
diluted with PBS to create three separate inocula with bacterial concentrations of 102 
CFU/0.1 mL, 104 CFU/0.1 mL, and 106 CFU/0.1 mL. One hundred microliters (100 μL) of 
each inoculum was drawn up into 1 mL syringes and stored on ice until time of 
administration.
Inoculation of Rat Intervertebral Discs
All animal procedures were approved by our Institutional Animal Care and Use Committee. 
Adult male Sprague-Dawley rats were purchased from Hilltop Lab Animals, Inc. (Scottdale, 
PA) and housed in our facility’s vivarium under a 12 hour light/dark cycle. Animals were 
provided access to food and water ad-libitum. Animals were given seven days to acclimate 
prior to the start of the study. Eighteen animals were randomly divided into the three 
inoculation groups (102 CFU/0.1 mL, 104 CFU/0.1 mL, and 106 CFU/0.1 mL). Animals 
were anesthetized using inhalational isoflurane, and the absence of a corneal reflex was used 
to confirm sedation. Puralube ointment was applied to both eyes and 5 mg/kg of carprofen 
was administered for analgesia. Following induction, the proximal tail segment was shaved 
and the three most proximal intervertebral segments distal to the coat/tail transition were 
identified using palpation. Calipers were used to measure the diameter at each segment, and 
half of that distance was transcribed onto the tip of a 27 gauge needle using a sterile marking 
pen. This measurement was used to approximate the depth of the center of the intervertebral 
disc. After prepping the injection area twice with an isopropyl alcohol swab, the sterile 27 
gauge needle was inserted in the third most proximal segment beginning in the dorsolateral 
position, taking care not to compromise vascular structures. After the calculated depth was 
reached, 100 μL of sterile PBS was injected into the nucleus pulposus as a sterile control. 
When the needle is positioned correctly, fluid flows with minimal resistance into the 
intervertebral disc. Next, 100 μL of one of the three bacterial concentrations was injected 
into the most proximal intervertebral disc, leaving a native intervertebral segment between 
the experimental and control segments.
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In-vivo Monitoring of Infection
The In-Vivo Imaging System (Lumina II, Perkin Elmer, Waltham, MA) and the Living 
Image software was used to quantify bioluminescence and was expressed in photons/second/
centimeter2 (p/sec/cm2). Animals were imaged at 0, 3, 7, 14, 21, 28, 35, and 42 days 
following injection. For these imaging sessions, animals were anesthetized using the 
integrated inhalational isoflurane system, and the tails were imaged in a dorsal position. 
Binning was set to large, field of view was set to D, and the capture time was 5 minutes. 
Baseline radiance was determined by imaging a non-inoculated rat at the same parameters as 
the infected rats.
Histological Analysis
Following euthanasia, three tissue samples of the affected tail segments from each injection 
group were randomly selected for histological analysis. Using rongeurs and scalpels, 
longitudinal corticotomies in the included vertebrae were created to allow infiltration of 10% 
formalin fixative. Samples were decalcified in Histoperfect Rapid Cal decal solution (BBC 
Biochemical, Mount Vernon, WA) until the bone was easily penetrated with a metal probe. 
Samples were then processed using 10% formalin, graded alcohols, xylenes, and finally 
paraffin. They were then prepared on a microtome at 5 microns and dried in a slide warming 
oven overnight and later stained with hematoxylin and eosin (H&E), safranin-O and fast 
green, and gram staining.
Post-Mortem Imaging
At euthanasia, one rat from each group underwent Faxitron radiographic imaging (Model 
#43805N, Faxitron, Tucson, AZ) to evaluate disc space narrowing and osseous bridging. To 
evaluate more fully the observed fusion characteristics at the disc segment, two animals 
inoculated with 104 CFU/0.1 mL (Group 2) inoculum were imaged using microCT (SkyScan 
1272, Bruker, Billerica, MA) following euthanasia.
Statistical analysis
Descriptive statistics, two way analysis of variance (ANOVA), and the Tukey post-test were 
used to compare the average radiance (p/sec/cm2) emitted between the three groups of 
animals and for each group at prescribed time points. Significance was set at p<0.05.
Results
IVIS Imaging
All animals survived until euthanasia and none exhibited signs of systemic infection. At day 
0, Group 3 (106 CFU/0.1 mL) was the only group that exhibited a statistically significant 
difference in radiance as compared to baseline (9,305 p/sec/cm2 vs. 2,900 p/sec/cm2, 
p=0.0026), but by the third day following injection, all groups exhibited significant increases 
in radiance from baseline (Group 1 = 12,402 p/sec/cm2, p<0.0001; Group 2 = 14,533 
p/sec/cm2, p<0.0001; Group 3 = 21,033 p/sec/cm2, p<0.001) (Figure 1). At one week, all 
groups continued to demonstrate significant increases in radiance from baseline 
measurements (group 1 = 8,403 p/sec/cm2, p=0.0134; group 2 = 10,278 p/sec/cm2, p=0.0004 
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group 3 = 16,837 p/sec/cm2, p<0.0001). By two weeks, no significant differences were 
observed in radiance measurements between infected groups and baseline. While radiance 
measurements between Groups 1 and 2 never differed significantly, Group 3 had statistically 
higher radiance measurements compared to Groups 1 and 2 on days 0, 3, and 7. 
Bioluminescence for each group peaked at day 3, and returned to baseline by day 21. 
Unexpectedly, we noted several specimens that developed bioluminescence in subcutaneous 
locations extending from the original injection site (Figure 2). Orthogonal IVIS imaging 
confirmed that this bacterial spread was subcutaneous in location and did not violate 
adjacent intervertebral disc spaces.
Histologic results
Samples processed using H&E, safranin-o and fast green, and gram staining were available 
for analysis (Figure 4). H&E analysis revealed abscess formation defined by a 
predominantly neutrophilic inflammatory infiltrate. Reactive bone formation in the context 
of inflammation and repair was noted at the periphery of the intervertebral segments. 
Safranin-O with fast green counterstain revealed complete destruction of the vertebral 
endplate and adjacent physis. Gram staining revealed gram positive bacteria retained within 
abscesses. Of note, bacteria were often found in association with necrotic bone fragments at 
the core of the abscesses. Staining of control segments revealed preserved structure without 
endplate disruption or inflammatory infiltration.
Radiologic results
At euthanasia, the affected vertebral segment was stiff to palpation, and therefore, Faxitron 
radiographic imaging was performed to qualitatively assess osseous changes (Figure 5). 
Infected segments showed no clear intervertebral disc space and formation of osteophytes, 
consistent with evolving, but incomplete osseous bridging. To further assess osseous 
changes at the affected segments, micro CT scan was performed on two specimens. Images 
showed incomplete trabecular bridging, destruction of vertebral endplates, and sequestrum 
formation (Figure 6). Control segments showed no radiographic changes.
Discussion
Despite a significant lack of consensus over the optimal route, duration, or class of 
antibiotic, medical management of spondylodiscitis has remained the same for several 
decades. The increasing number of patients with immunosuppression as well as the growing 
incidence of antibiotic resistant bacteria emphasizes the expanding need for better 
conservative management of spondylodiscitis. The present study describes a preclinical 
model that permits objective, real-time, efficient evaluation of novel therapeutics for the 
treatment of spondylodiscitis without the need to euthanize the animal to determine the 
impact on infection.
To our knowledge, this is the first model of spondylodiscitis to use bioluminescent bacteria 
for the visualization and quantification of intervertebral disc infection. This model has the 
potential to improve the ability to increase study sample sizes while minimizing expenses of 
spondylodiscitis studies. Established models of spine infection typically utilize larger 
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animals and require paravertebral muscle dissection, intraoperative fluoroscopy, and 
intensive anesthesia protocols15–24. Furthermore, these models require euthanasia at specific 
time points to evaluate infection intensity. These factors increase the number of animals 
required to execute infection studies, and as a result increase the associated costs of these 
studies. Because this model uses a simple inoculation procedure and does not require 
euthanasia to study therapeutic effect over time, the use of bioluminescent bacteria in rat 
tails could significantly reduce these costs.
In the present study, we simulated spondylodiscitis by injecting S. aureus directly into the 
intervertebral disc. Detected bioluminescence was most intense at 7 days and returned to 
baseline by 21 days. The decrease in bioluminescence at 21 days was likely due to depletion 
of the nutrient environment, reduction in bacterial counts secondary to immunologic attack, 
and sequestration of bacteria by the immune environment. Each group exhibited a spike in 
bioluminescence between day 3 and 7 followed by a linear decline to baseline at day 21. 
These findings indicate that seeding of the intervertebral disc is followed by a logarithmic 
bacterial growth phase. As the infection expands and approaches immunologically active 
vertebral endplates, planktonic bacteria is eliminated by host defenses. Additionally, bacteria 
begin to form biofilm and enter a state of senescence, further decreasing the emitted 
bioluminescent signal26; 28–31
Another unique aspect of this model is the use of the rat tail vertebral column for the 
simulation of spondylodiscitis. This location allows for easier inoculation and clinical 
evaluation when compared to models that use a more proximal spinal section. Most cases of 
clinical spondylodiscitis begin secondary to hematogenous seeding of the vertebral endplates 
by way of metaphyseal arteries32. In this model, we injected bacteria directly into the disc to 
induce infection. While this method of bacterial seeding differs from the pathologic etiology 
in humans, our tissue analysis demonstrates histologic and radiographic findings similar to 
clinical spondylodiscitis.
An unexpected finding was that retained bacteria within the core of intervertebral abscesses 
were nearly always associated with necrotic bone. While we were also able to identify 
sequestrum formation on micro CT, the finding of necrotic bone in proximity to retained 
bacteria was distinct. The importance of this finding is as yet unclear, but suggests that 
necrotic bone fragments might provide shelter for bacteria from immunologic defenses.
It is important to note that there are some limitations to this described model. First, we noted 
bioluminescence in a subcutaneous location extending from the inoculation site. These 
findings are consistent with the induction of a soft tissue infection, and is likely due to 
extravasation of the inoculum from the injection site into surrounding tissues. Future 
experiments using this model should use a smaller volume of inoculum and a smaller 
injection needle to limit elution from the intervertebral disc. Second, because an injection 
was used to introduce bacteria into the intervertebral disc space, the effects of the needle 
puncture injury on disc architecture were not directly assessed. While established animal 
models of disc degeneration use annular puncture to induce degeneration, we did not 
observe these effects in our control segments. Recent studies suggest that the degeneration 
associated with these injuries is based on needle gauge and that needle sizes similar to the 
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ones in this study can be used for the delivery of therapeutics to the intradiscal environment 
without inducing degeneration33; 34. Future studies could more fully characterize the 
degenerative sequelae associated with the needle stick if undisturbed vertebral segments 
were used as controls. Third, we noted the presence of bacteria at euthanasia despite the lack 
of detected bioluminescent signal. This is likely due to bacterial counts that do not exceed 
the threshold required for detection. While the concentrations of bacteria used in this study 
are relevant for acute spondylodiscitis, this model is unlikely to adequately simulate an 
indolent infection. Lastly, the present study did not include an interventional arm and, as a 
result, further investigation is necessary to determine the ability of this model to detect 
therapeutic effect. Although these are real limitations, histological and radiographic analysis 
are consistent with a host reaction to spondylodiscitis, supporting the validity of this animal 
model.
This model might also be enhanced by volumetric micro CT analysis of the tail vertebra as a 
means to quantify changes in reactive bone formation, loss of intervertebral space, and 
osteolysis between treated and untreated groups. Our qualitative micro CT analysis 
demonstrated reactive bone formation and extensive osteolysis of adjacent vertebral 
endplates. Indeed, prior rodent models of infection have demonstrated the utility of assessing 
these differences between treatment and control groups as a proxy for therapeutic effect, and 
quantitative analysis of these bony changes is likely to strengthen this model26; 37.
Implementation of this model may ease the burden and associated expense of executing 
preclinical studies of spondylodiscitis and facilitate investigations into antibiotic and novel 
biologic treatments for the conservative management of spondylodiscitis. Although surgery 
can be used to eradicate infections that fail medical management, the significant morbidity 
associated with these procedures as well as the inability of surgery by itself to cure the 
infection demands better biological interventions. The present study describes a preclinical 
model that permits objective, real-time, and efficient evaluation of novel therapeutics for the 
treatment of spondylodiscitis.
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Bioluminescent results over time. Radiance returned to baseline by day 21 (left). Radiance 
intensity overlaid on grayscale image of subjects (right).
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Bioluminescent intensity map demonstrating subcutaneous spread of bacteria from site of 
inoculation (A). Orthogonal imaging revealed that this signal originates from a subcutaneous 
position (B).
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A: H&E staining of control intervertebral segments. Normal architecture is preserved. B: 
H&E staining of infected intervertebral segment. Reactive bone formation (**), and abscess 
(*) are noted. Original position of endplate is noted (<). C: Gram staining of infected 
segment demonstrates abscesses (*) and reactive bone formation (**). D: Gram stain 
demonstrates bacteria in proximity to necrotic bone. E: Safranin-O and fast green staining of 
the control disc. F: Safranin-O staining of infected disc demonstrating endplate destruction 
and trabecular bridging (arrow). Remnants of the cartilaginous endplate are noted (++).
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Faxitron imaging of infected and uninfected segments. No intervertebral space is noted at 
the infected area (arrow).
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Micro CT images of uninfected (A) and infected (B & C) segments. Reactive bone 
formation is noted at the periphery of the infected segments. Partial trabecular bridging is 
also noted. Sequestrum formation is evident near the endplate (C).
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Percent radiance of recovered bacteria compared to stock solution. No significant differences 
noted between groups.
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